Your browser doesn't support javascript.
loading
Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan.
Younis, Brima M; Osman, Mohamed; Khalil, Eltahir A G; Santoro, Francesco; Furini, Simone; Wiggins, Rebecca; Keding, Ada; Carraro, Monica; Musa, Anas E A; Abdarahaman, Mujahid A A; Mandefield, Laura; Bland, Martin; Aebischer, Toni; Gabe, Rhian; Layton, Alison M; Lacey, Charles J N; Kaye, Paul M; Musa, Ahmed M.
Affiliation
  • Younis BM; Department of Clinical Pathology & Immunology, Institute of Endemic Diseases, University of Khartoum, Army Ave., Khartoum, Sudan.
  • Osman M; York Biomedical Research Institute, Hull York Medical School, University of York, Heslington, York YO10 5DD, UK.
  • Khalil EAG; Department of Clinical Pathology & Immunology, Institute of Endemic Diseases, University of Khartoum, Army Ave., Khartoum, Sudan.
  • Santoro F; Department of Medical Biotechnologies, University of Siena, Siena 53100, Italy.
  • Furini S; Department of Medical Biotechnologies, University of Siena, Siena 53100, Italy.
  • Wiggins R; York Biomedical Research Institute, Hull York Medical School, University of York, Heslington, York YO10 5DD, UK.
  • Keding A; Department of Health Sciences, University of York, Heslington, York YO10 5DD, UK.
  • Carraro M; Department of Medical Biotechnologies, University of Siena, Siena 53100, Italy.
  • Musa AEA; Department of Clinical Pathology & Immunology, Institute of Endemic Diseases, University of Khartoum, Army Ave., Khartoum, Sudan.
  • Abdarahaman MAA; Department of Clinical Pathology & Immunology, Institute of Endemic Diseases, University of Khartoum, Army Ave., Khartoum, Sudan.
  • Mandefield L; Department of Health Sciences, University of York, Heslington, York YO10 5DD, UK.
  • Bland M; Department of Health Sciences, University of York, Heslington, York YO10 5DD, UK.
  • Aebischer T; Robert Koch Institute, 13353 Berlin, Germany.
  • Gabe R; Wolfson Institute of Preventive Medicine, Queen Mary University of London, London E1 4NS, UK.
  • Layton AM; York Biomedical Research Institute, Hull York Medical School, University of York, Heslington, York YO10 5DD, UK.
  • Lacey CJN; York Biomedical Research Institute, Hull York Medical School, University of York, Heslington, York YO10 5DD, UK.
  • Kaye PM; York Biomedical Research Institute, Hull York Medical School, University of York, Heslington, York YO10 5DD, UK. Electronic address: paul.kaye@york.ac.uk.
  • Musa AM; Department of Clinical Pathology & Immunology, Institute of Endemic Diseases, University of Khartoum, Army Ave., Khartoum, Sudan. Electronic address: musaam2003@yahoo.co.uk.
Mol Ther ; 29(7): 2366-2377, 2021 07 07.
Article in En | MEDLINE | ID: mdl-33781913
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines, Synthetic / Leishmaniasis, Cutaneous / CD8-Positive T-Lymphocytes / Leishmaniasis Vaccines / Leishmania / Antigens, Protozoan Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Child / Female / Humans / Male Language: En Journal: Mol Ther Journal subject: BIOLOGIA MOLECULAR / TERAPEUTICA Year: 2021 Document type: Article Affiliation country: Sudan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines, Synthetic / Leishmaniasis, Cutaneous / CD8-Positive T-Lymphocytes / Leishmaniasis Vaccines / Leishmania / Antigens, Protozoan Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Child / Female / Humans / Male Language: En Journal: Mol Ther Journal subject: BIOLOGIA MOLECULAR / TERAPEUTICA Year: 2021 Document type: Article Affiliation country: Sudan